Search results for: 'Cancer Diagnostics Market'

This research service investigates technologies that propel the development of new targeted immunotherapies, particularly those that deliver therapeutic DNA and proteins. The top 3 growth opportunities focus on enhanced gene delivery systems for greater precision, the support of such systems through novel biotech platforms, and the affordability of...

Ultrasound is a rapidly growing field, constantly evolving to overcome challenges in diagnosing and treating broad-spectrum disorders. In recent years, emerging technologies in ultrasound medical imaging have gained significant interest because of their potential to revolutionize the field, creating promising opportunities for technology developers...

The procedure for accurately identifying a biomarker correlation based on a patient s genetic makeup is complex and relies on the expertise and knowledge of an oncologist, decision-support scientist, or other healthcare professional involved in the matching process. Precision oncology aims to provide oncologists with diagnosis, prognosis, and treat...

Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...

Clinical decision support systems (CDSS) provide actionable information for improving the decision making abilities of the health professionals. However, the traditional CDSS platforms have drawbacks such as alert fatigue, diagnostic errors, workflow disruptions that can have detrimental effect on patients health outcomes as well as healthcare prov...

The global medical imaging equipment and informatics industry is undergoing a structural transformation, driven by rising demand for diagnostic procedures, increasing prevalence of chronic diseases, and growing imaging volumes across care settings. The shift toward value-based care, coupled with the expansion of precision medicine, is accelerating ...

The commercial vehicle industry is undergoing a major transformation, fueled by rapid technological advancements and rising demand for efficiency, safety, and sustainability. A standout innovation in this shift is prognostics, which is the ability to predict vehicle health and performance based on real-time data. This study takes a deep dive into p...

The programmable power supply (PPS) market is expected to witness a medium-to-high growth rate during the forecast period (2025-2030), driven by factors such as demand for devices that can provide stable and clean power, consumer demand for high-quality products tested under various conditions, and stringent regulations to ensure compliance with st...

Both predictive and prognostic biomarkers constitutes an central element in each and every targeted oncology drug discovery and development program. Breakthrough technologies allowing leveraging biomarkers for oncology are paving the way of personalized medicine and precision oncology. Indeed, oncology biomarkers provide the clinical community with...